Association of disease‐free survival and percent of ideal dose in adjuvant breast chemotherapy Journal Article


Authors: Geller, N. L.; Hakes, T. B.; Petroni, G. R.; Currie, V.; Kaufman, R.
Article Title: Association of disease‐free survival and percent of ideal dose in adjuvant breast chemotherapy
Abstract: The relationship between percent of ideal dose and disease‐free survival was examined in 256 Stage II and III patients who participated in a 2‐year breast adjuvant chemotherapy trial consisting of cyclophosphamide, methotrexate, and 5‐fluorouracil (CMF) given postoperatively. When analyzed analogously to previous work, the results confirmed a dose‐response relationship: that is, there appeared to be an improved disease‐free survival for patients receiving higher doses of adjuvant chemotherapy. The major criticism of such an analysis is its bias. This bias was addressed by considering only patients who were still receiving therapy at 6, 12, and 24 months; then, the dose‐response relationship was no longer seen. Although causality cannot be inferred, the apparent differences in disease‐free survival among the dose groups can be attributed to recurrences in the first 2 years among patients receiving lower doses of chemotherapy. Copyright © 1990 American Cancer Society
Keywords: survival; survival analysis; retrospective studies; major clinical study; fluorouracil; combined modality therapy; methotrexate; breast cancer; antineoplastic combined chemotherapy protocols; cyclophosphamide; dose-response relationship, drug; breast neoplasms; data interpretation, statistical; adjuvant chemotherapy; drug dose; menopause; intravenous drug administration; oral drug administration; levamisole; human; female; priority journal; article; support, u.s. gov't, p.h.s.
Journal Title: Cancer
Volume: 66
Issue: 8
ISSN: 0008-543X
Publisher: Wiley Blackwell  
Date Published: 1990-10-15
Start Page: 1678
End Page: 1684
Language: English
DOI: 10.1002/1097-0142(19901015)66:8<1678::Aid-cncr2820660804>3.0.Co;2-r
PUBMED: 2208022
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 27 January 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Violante Currie
    51 Currie
  2. Thomas B Hakes
    115 Hakes
  3. Richard J Kaufman
    13 Kaufman
  4. Nancy L. Geller
    65 Geller